Specify a stock or a cryptocurrency in the search bar to get a summary
Nanexa AB
NANEXANanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia; NEX-20 for the treatment of multiple myeloma; and NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden. Address: Virdings Allle 32B, Uppsala, Sweden, 75450
Analytics
WallStreet Target Price
33.63 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NANEXA
Dividend Analytics NANEXA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NANEXA
Stock Valuation NANEXA
Financials NANEXA
Results | 2019 | Dynamics |